Masimo

Masimo is a global medical technology company founded in 1989 with the slogan "Improving life." The company is listed on NASDAQ under the ticker symbol MASI. Masimo specializes in developing and manufacturing innovative noninvasive patient monitoring technologies and medical devices, as well as a wide array of sensors. Their work aims at improving patient outcomes and reducing the cost of care.

With a focus on biotechnology, healthcare, and manufacturing, Masimo's innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems for over 30 years. The company's portfolio of clinically-proven products leads the way in innovation, performance, and patient safety, providing healthcare providers with the information they need to optimize clinical decision-making.

The company's last investment of $750.00M in post-IPO equity was made on 15 August 2022 by Politan Capital Management. Masimo seeks individuals who are forward-thinkers and are committed to making a difference.

Based in the United States, Masimo is dedicated to making a measurable difference in the world by saving, extending, and improving the lives of people from all walks of life. Their commitment to innovation and patient care makes them a compelling prospect in the medical technology industry.